Cited by 192Sleep and related disordersCircadian rhythm and melatoninSleep and Work-Related Fatigue

The DOI matches its Crossref record; 178 of the 181 references it cites were found in a registry or an index; 8 of the 215 sources its claims cite were checked for support.

Interacting epidemics? Sleep curtailment, insulin resistance, and obesity

Open access
Lucassen, Eliane A., Rother, Kristina I., Cizza, Giovanni·2012·Annals of the New York Academy of Sciences

Abstract

In the last 50 years, the average self‐reported sleep duration in the United States has decreased by 1.5–2 hours in parallel with an increasing prevalence of obesity and diabetes. Epidemiological studies and meta‐analyses report a strong relationship between short or disturbed sleep, obesity, and abnormalities in glucose metabolism. This relationship is likely to be bidirectional and causal in nature, but many aspects remain to be elucidated. Sleep and the internal circadian clock influence a host of endocrine parameters. Sleep curtailment in humans alters multiple metabolic pathways, leading to more insulin resistance, possibly decreased energy expenditure, increased appetite, and immunological changes. On the other hand, psychological, endocrine, and anatomical abnormalities in individuals with obesity and/or diabetes can interfere with sleep duration and quality, thus creating a vicious cycle. In this review, we address mechanisms linking sleep with metabolism, highlight the need for studies conducted in real‐life settings, and explore therapeutic interventions to improve sleep, with a potential beneficial effect on obesity and its comorbidities.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review argues that short or disturbed sleep is bidirectionally linked with obesity, insulin resistance, and type 2 diabetes through endocrine, metabolic, immune, and circadian pathways. It concludes that improving sleep may help counter obesity/diabetes epidemics, but causality and optimal interventions remain unresolved.

Key findings

  • In the last 50 years, average self-reported U.S. sleep duration decreased by 1.5–2 hours alongside rising obesity and diabetes; a meta-analysis of 45 cross-sectional studies (604,509 adults, 30,002 children) found short sleep associated with obesity (OR 1.55, 95% CI 1.43–1.68 in adults; OR 1.89, 95% CI 1.46–2.43 in children).
  • Short sleep is associated with diabetes: a study of 174,542 middle-aged subjects reported OR 1.46 (1.31–1.63) after 3–10 years, and a meta-analysis of 10 prospective studies reported pooled OR 1.28 (1.03–1.60), with the association present only in men (OR 2.07; 1.16–3.72).
  • Experimental sleep curtailment impairs glucose metabolism: e.g., 20% increase in insulin resistance by ivGTT and 11% by clamp after 7 nights of 5-hour bedtimes; 21% increased insulin resistance after 3 nights of 4-hour bedtimes in type 1 diabetes; 25% increased insulin resistance after sleep fragmentation.
  • Sleep loss also alters appetite/energy balance: increased hunger, increased food intake (e.g., 22% in one study; 12% in another), decreased leptin (~18% after partial sleep deprivation), increased ghrelin, and reduced resting/postprandial energy expenditure in some acute studies.

Methods

  • Narrative review synthesizing epidemiologic evidence, meta-analyses, physiological studies of normal sleep, and experimental human sleep-curtailment studies.
  • Central evidence table summarizes 37 human experimental studies of total sleep deprivation, partial sleep deprivation, and sleep fragmentation, with outcomes including glucose tolerance, insulin sensitivity, energy expenditure, appetite hormones, cortisol, thyroid hormones, GH, sympathovagal balance, and inflammatory markers.
  • The review also discusses reverse pathways (obesity/diabetes affecting sleep), circadian/melatonin mechanisms, and proposed therapeutic interventions; no new primary data are reported.

Limitations

  • The paper states that causality remains unclear even in prospective studies, because sleep extension/curtailment cannot be blinded and participants may not adhere to allocation; existing prospective studies are observational.
  • The paper states that experimental studies are mostly acute, conducted in healthy lean volunteers, not in real-life settings, often with small sample sizes and variable control of food intake and physical activity; effects may differ in chronic sleep deprivation, natural short sleepers, obese/insulin-resistant individuals, and chronic insomniacs.
  • The paper notes that epidemiologic studies often lack objective sleep duration measurement, that experimental studies are mostly conducted in males, and that melatonin’s metabolic benefits remain unproven in rigorous randomized trials; evident from the text, many findings are heterogeneous and some are based on very small samples.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1111/j.1749-6632.2012.06655.x

Cites

178 of 178 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Representative sleep architecture during eight hours of uninterrupted sleep (adapted from Ref. 39). Sleep can be divided into rapid eye movement (REM) and nonrapid eye movement (NREM) sleep. On average, adults spend 75–80% in NREM sleep, which can be further subdivided into stages 1 to 4. Stages 3 and 4 are often referred to as slow-wave sleep (SWS) because of the appearance of well-defined waves of 0.5–4.0 Hz. In REM sleep, a phasic and a tonic phase can be distinguished. Skeletal muscles are atonic or hypotonic during REM sleep (except for the diaphragm, extraocular, and sphincter muscles), but bursts of muscle activity can occur during the phasic phase. Furthermore, dreams mostly take place during REM sleep and are more complex during this stage. Eye movement is only present during the phasic phase. Throughout a normal night of sleep, there are three to five sleep cycles, from NREM (stage 1 to 4) to REM, each cycle taking 90–120 minutes. Humans display less SWS and more REM sleep toward the end of the night.
Figure 1 Representative sleep architecture during eight hours of uninterrupted sleep (adapted from Ref. 39). Sleep can be divided into rapid eye movement (REM) and nonrapid eye movement (NREM) sleep. On average, adults spend 75–80% in NREM sleep, which can be further subdivided into stages 1 to 4. Stages 3 and 4 are often referred to as slow-wave sleep (SWS) because of the appearance of well-defined waves of 0.5–4.0 Hz. In REM sleep, a phasic and a tonic phase can be distinguished. Skeletal muscles are atonic or hypotonic during REM sleep (except for the diaphragm, extraocular, and sphincter muscles), but bursts of muscle activity can occur during the phasic phase. Furthermore, dreams mostly take place during REM sleep and are more complex during this stage. Eye movement is only present during the phasic phase. Throughout a normal night of sleep, there are three to five sleep cycles, from NREM (stage 1 to 4) to REM, each cycle taking 90–120 minutes. Humans display less SWS and more REM sleep toward the end of the night.CC BY · PubMed Central
Figure 2 Mean levels of metabolic parameters and sleep stages in lean young men (n = 8 for TSH, cortisol, GH, melatonin, SWS, and REM sleep;48n = 14 for insulin, glucose, total and acetylated ghrelin;76n = 8 for catecholamines73); in 23 lean women for leptin and adiponectin;69 and in 25 individuals (13 females, 12 males) for IL-6 and TNF-α.83 Ghrelin levels are indicated as a percent of mean 24-h values (1027 pg/mL for total ghrelin; 80 pg/mL for acetylated ghrelin); leptin levels are shown as percent change from levels at 08:00. Dark bars below each plot indicate bedtimes. Sleep was monitored polysomnographically during all measurements. Striped bars indicate meal times. Modified, with permission Refs. 48, 69, 73, 76, and 83
Figure 2 Mean levels of metabolic parameters and sleep stages in lean young men (n = 8 for TSH, cortisol, GH, melatonin, SWS, and REM sleep;48n = 14 for insulin, glucose, total and acetylated ghrelin;76n = 8 for catecholamines73); in 23 lean women for leptin and adiponectin;69 and in 25 individuals (13 females, 12 males) for IL-6 and TNF-α.83 Ghrelin levels are indicated as a percent of mean 24-h values (1027 pg/mL for total ghrelin; 80 pg/mL for acetylated ghrelin); leptin levels are shown as percent change from levels at 08:00. Dark bars below each plot indicate bedtimes. Sleep was monitored polysomnographically during all measurements. Striped bars indicate meal times. Modified, with permission Refs. 48, 69, 73, 76, and 83CC BY · PubMed Central
Figure 3 A simplified schematic representation of putative pathways of sleep curtailment leading to obesity and diabetes, via endocrine mechanisms that stimulate appetite, decrease energy expenditure, and increase insulin resistance. The direction of change (an increase or decrease) of each mechanism due to sleep loss is displayed; increased sympathovagal balance could stimulate EE, depicted by +, while a decreased EE would contribute to obesity. For readability, the relationships between decreases in leptin levels associated with IL-6 and TNF-α production are not displayed. Cortisol and proinflammatory cytokines display a positive bidirectional relationship. Increased insulin levels stimulate orexin secretion and orexic arcuate neurons, while decreasing the activity of anorexic arcuate neurons, leading to a further increase in appetite. Adiponectin influences energy homeostasis, possibly via modulating appetite through arcuate neurons and modulating EE.
Figure 3 A simplified schematic representation of putative pathways of sleep curtailment leading to obesity and diabetes, via endocrine mechanisms that stimulate appetite, decrease energy expenditure, and increase insulin resistance. The direction of change (an increase or decrease) of each mechanism due to sleep loss is displayed; increased sympathovagal balance could stimulate EE, depicted by +, while a decreased EE would contribute to obesity. For readability, the relationships between decreases in leptin levels associated with IL-6 and TNF-α production are not displayed. Cortisol and proinflammatory cytokines display a positive bidirectional relationship. Increased insulin levels stimulate orexin secretion and orexic arcuate neurons, while decreasing the activity of anorexic arcuate neurons, leading to a further increase in appetite. Adiponectin influences energy homeostasis, possibly via modulating appetite through arcuate neurons and modulating EE.CC BY · PubMed Central

Verification

Claims the paper makes

107 Not checked yet · 36 Own interpretation · 25 No basis given · 3 Partly supported · accuracy not yet measured

Verify all 207 references — free account

Show all 78 claims

  • It may state two separate claims as one. 58
  • Probably not a substantial claim. 45
93 of 93
  • The paper relies on this without support.

    The exact mechanisms explaining the relationship between short sleep, obesity, and diabetes remain unclear.

    “The exact mechanisms explaining the relationship between short sleep, obesity, and diabetes remain unclear.”
  • The paper relies on this without support.

    Insulin resistance can result from increases in insulin counter-regulatory hormones, including GH and cortisol.

    “Insulin resistance can result from increases in insulin counter-regulatory hormones, including GH and cortisol (Fig. 3).”
  • The paper relies on this without support.

    Decreased adiponectin levels worsen insulin resistance.

    “Besides influencing energy homeostasis, decreased adiponectin levels worsen insulin resistance.”
  • The paper relies on this without support.

    Leptin inhibits appetite and ghrelin stimulates appetite.

    “Leptin and ghrelin inhibit and stimulate appetite, respectively (Fig. 3).”
  • The paper relies on this without support.

    In obese subjects, leptin levels are elevated but several of its actions are impaired (leptin resistance).

    “In obese subjects, leptin levels are elevated but several of its actions are impaired, a concept referred to as leptin resistance.”
  • The paper relies on this without support.

    The melatonin receptor 1B is present on pancreatic β-cells, and melatonin has an inhibitory effect on insulin secretion.

    “Interestingly, the melatonin receptor 1B is present on pancreatic β-cells, and melatonin has an inhibitory effect on insulin secretion.”
  • The paper relies on this without support.

    Sleep is regulated by circadian and homeostatic mechanisms.

    “Sleep is regulated by circadian and homeostatic mechanisms.”
  • The paper relies on this without support.

    There is large individual variability in sleep needs.

    “Nevertheless, it is certain that there is a large individual variability in sleep needs.”
  • The paper relies on this without support.

    Chronotype modulates metabolism.

    “Chronotype, the individual attribute determining morning or evening preference, modulates metabolism.”
  • The paper relies on this without support.

    Seasonality is greatly attenuated in modern humans due to artificial lighting and other environmental modifications.

    “As a consequence of artificial lighting and other environmental modifications, seasonality is greatly attenuated in modern humans.”
  • The paper relies on this without support.

    Melatonin promotes sleep.

    “As melatonin promotes sleep, the decrease in obesity and improvement in insulin resistance could be due to longer and better sleep per se, but it could also relate to other melatonin-dependent pathways yet to be identified (Fig. 3).”
  • The paper relies on this without support.

    Sleep deprivation is more common in minorities.

    “Similarly, sleep deprivation is more common in minorities but the effects of socioeconomic status per se versus ethnicity remain to be determined.”
  • The paper relies on this without support.

    Individual susceptibility within these categories varies greatly.

    “Individual susceptibility within these categories varies greatly: identification of contributing factors will greatly help prevention and treatment and be one of the tenets of individualized medicine.176”
  • The paper relies on this without support.

    The biological need for optimal sleep duration varies and cannot be estimated at an individual level.

    “As already mentioned, causality can be addressed best in long-term studies where “prescribed” sleep duration is randomized, but this may present with practical difficulties and significant challenges, including the fact that the biological need for optimal sleep duration varies and cannot be estimated at an individual level.”
  • The paper relies on this without support.

    Classic experiments of parabiosis support the notion of endogenous sleep-promoting substances.

    “Classic experiments of parabiosis seem to support the notion of endogenous “sleep-promoting” substances.”
  • The paper relies on this without support.

    ob/ob mice that lack leptin and db/db mice that lack the leptin receptor both display sleep disturbances that are reverted by leptin replacement.

    “Furthermore, ob/ob mice that lack leptin and db/db mice that lack the leptin receptor, both display sleep disturbances that are reverted by leptin replacement.”
  • The paper relies on this without support.

    Short sleep has negative effects on health.

    “At this point, there is a general consensus that short sleep has negative effects on health”
  • The paper relies on this without support.

    Sleep curtailment causes metabolic disturbances.

    “the amount of sleep curtailment causing metabolic disturbances is unclear”
  • The paper relies on this without support.

    The amount of sleep curtailment causing metabolic disturbances is unclear.

    “the amount of sleep curtailment causing metabolic disturbances is unclear”
  • The paper relies on this without support.

    Specific groups at greater risk are yet to be identified.

    “specific groups at greater risk are yet to be identified”
  • The paper relies on this without support.

    Whether melatonin would benefit obese/diabetic subjects, or a subset of these individuals, remains to be proven in rigorous randomized clinical trials.

    “Whether melatonin would benefit obese/diabetic subjects, or a subset of these individuals, remains to be proven in rigorous randomized clinical trials.”
21 of 21

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

6 of 6

Citations

Cites

Show all 181 references

Research works printed but not linked: 2

  1. National Sleep Foundation, 2005, Sleep in America Poll
  2. Garfinkel D., 2011, Efficacy and safety of prolonged‐release melatonin in insomnia patients with diabetes: a randomized, double‐blind, crossover study, Diabetes Metab. Syndr. Obes., 4, 307

Cited by

Sorted by citations

See all 192

Metadata

Authors
Lucassen, E. A., Rother, K. I., & Cizza, G.
Affiliations
National Institutes of Health (US)
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
2012-07-24
Volume
1264
Issue
1
Pages
110-134
ISSN
  • 0077-8923 (ISSN-L)
  • 1749-6632
OpenAlex
W1711695767
Cited by
191
References
181
Citations by year
2026: 2 · 2025: 7 · 2024: 9 · 2023: 16 · 2022: 16 · 2021: 16 · 2020: 11 · 2019: 10 · 2018: 15 · 2017: 13 · 2016: 17 · 2015: 19 · 2014: 25 · 2013: 14 · 2012: 1
FWCI
2.76
Type
journal article
Language
en
Open access
Locations
  • Annals of the New York Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
Funders
  • Universiteit Leiden
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (ZIADK047054)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and Work-Related Fatigue
Keywords
sleep duration, sleep disorders, obesity, insulin resistance, diabetes mellitus, glucose metabolism, circadian clock, energy expenditure, appetite, sleep quality, sleep interventions
MeSH terms
Appetite, Diabetes Mellitus, Energy Metabolism, Female, Glucose, Humans, Insulin Resistance, Male, Melatonin, Obesity, Risk Factors, Sleep Deprivation, Sleep Wake Disorders, Leptin, Adiponectin, Ghrelin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review